Skip to content

MDMA research published in 2015

Page 2 of 3: studies 21 to 40 of 43, newest first. Back to the MDMA overview

Studies

Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus.

Brain Research May 22, 2015 Dmitry V Zaretsky, Maria V Zaretskaia, Pamela J Durant et al.

The contribution of exercise to hyperthermia mediated by MDMA is not known. We recently showed that inhibiting the dorsomedial hypothalamus (DMH) attenuated spontaneous locomotion and hyperthermia and prevented deaths in rats given MDMA in a warm environment. The goal of this study was to confirm that restoring locomotion through a treadmill would reverse these effects thereby confirming that...

Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices

Journal of Psychopharmacology May 18, 2015 Sunjeev K. Kamboj, Emma J. Kilford, Stephanie Minchin et al. 43 citations

3,4-methylenedioxy- N-methylamphetamine (MDMA) produces diverse pro-social effects. Cognitive training methods rooted in Eastern contemplative practices also produce these effects through the development of a compassionate mindset. Given this similarity, we propose that one potential mechanism of action of MDMA in psychotherapy is through enhancing effects on intrapersonal attitudes (i.e....

DOI: 10.1177/0269881115587143 (opens in new tab) Ecstasy MDMA Psychopharmacology Recreational drug +3

Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA

Behavioural Pharmacology May 14, 2015 María Pilar García-pardo, Carla Escobar-Valero, Marta Rodrı́guez-arias et al. 29 citations

Some 3,4-methylenedioxymethamphetamine (MDMA) users become dependent as a result of chronic consumption. A greater understanding of the neurobiological basis of the rewarding effects of MDMA could contribute to developing effective pharmacotherapies for MDMA-related problems. The present study evaluated the role of N-methyl-D-aspartate (NMDA) glutamate receptors (NMDARs) in the acquisition and...

DOI: 10.1097/fbp.0000000000000138 (opens in new tab) MDMA Addiction Conditioned place preference Memantine +5

fNIRS suggests increased effort during executive access in ecstasy polydrug users.

Psychopharmacology May 2015 C A Roberts, C Montgomery

Ecstasy use is associated with cognitive impairment, believed to result from damage to 5-HT axons. Neuroimaging techniques to investigate executive dysfunction in ecstasy users provide a more sensitive measure of cognitive impairment than behavioural indicators. The present study assessed executive access to semantic memory in ecstasy polydrug users and non-users. Twenty ecstasy polydrug users...

Intimate insight: MDMA changes how people talk about significant others

Journal of Psychopharmacology April 29, 2015 Matthew J. Baggott, Matthew G. Kirkpatrick, Gillinder Bedi et al. 69 citations

Rationale: ±3,4-methylenedioxymethamphetamine (MDMA) is widely believed to increase sociability. The drug alters speech production and fluency, and may influence speech content. Here, we investigated the effect of MDMA on speech content, which may reveal how this drug affects social interactions. Method: Thirty-five healthy volunteers with prior MDMA experience completed this two-session,...

Dropping Ecstasy? Minoan Cult and the Tropes of Shamanism

Time and Mind April 3, 2015 Caroline Tully, Sam Crooks 20 citations

Cult scenes illustrated in miniature on administrative stone seals and metal signet rings from Late Bronze Age Minoan Crete are commonly interpreted as “Epiphany Scenes” and have been called “shamanic”. “Universal shamanism” is a catch-all anthropological term coined to describe certain inferred ritual behaviors across widely dispersed cultures and through time. This study re-examines evidence...

Effects of 3,4‐Methylenedioxypyrovalerone (MDPV) and 3,4‐Methylenedioxymethamphetamine (MDMA) on Place Conditioning in Mice

The FASEB Journal April 1, 2015 Brenda M. Gannon, Julia Tobacyk, William E Fantegrossi

Recently, there has been an increase in abuse of new synthetic psychostimulant drugs derived from the cathinone structure. These products are typically referred to as “bath salts”, and one of the most common psychoactive constituents of these preparations is 3,4‐methylenedioxypyrovalerone (MDPV). In these studies, we used the conditioned place preference (CPP) paradigm to explore the apparent...

Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.

Journal of Pharmacology and Experimental Therapeutics April 2015 Yasmin Schmid, Anna Rickli, Antonia Schaffner et al.

3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a popular recreational drug. The aim of the present study was to explore the role of dopamine in the psychotropic effects of MDMA using bupropion to inhibit the dopamine and norepinephrine transporters through which MDMA releases dopamine and norepinephrine by investigating. The pharmacodynamic and pharmacokinetic interactions between...

Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary

Drug Science, Policy and Law March 24, 2015 Ben Sessa, Friederike Meckel Fischer 39 citations

Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a Zurich-based psychotherapist providing individual and group psycholytic psychotherapy, whose practice persisted for several years before she was arrested in 2009. The article provides commentary on...

DOI: 10.1177/2050324515578080 (opens in new tab) MDMA Psychotherapist Mainstream Context archaeology +2

Pharmacological profile of novel psychoactive benzofurans

British Journal of Pharmacology March 13, 2015 Anna Rickli, Simone Kopf, Marius C. Hoener et al. 115 citations

Background and Purpose Benzofurans are newly used psychoactive substances, but their pharmacology is unknown. The aim of the present study was to pharmacologically characterize benzofurans in vitro . Experimental Approach We assessed the effects of the benzofurans 5‐ APB , 5‐ APDB , 6‐ APB , 6‐ APDB , 4‐ APB , 7‐ APB , 5‐ EAPB and 5‐ MAPDB and benzodifuran 2 C ‐ B ‐ FLY on the human...

DOI: 10.1111/bph.13128 (opens in new tab) MDMA Monoamine neurotransmitter Pharmacology Receptor +2

Designer drugs 2015: assessment and management

Addiction Science & Clinical Practice March 11, 2015 Michael F. Weaver, John A. Hopper, Erik W. Gunderson 135 citations

Recent designer drugs, also known as "legal highs," include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as "bath salts"); synthetic cannabinoids (SCs; e.g., Spice); and synthetic hallucinogens (25I-NBOMe, or N-bomb). Compound availability has evolved rapidly to evade legal regulation and detection by routine drug testing. Young adults...

Prosocial effects of MDMA: A measure of generosity

Journal of Psychopharmacology March 4, 2015 Matthew G. Kirkpatrick, Andrew W. Delton, Theresa E. Robertson et al. 86 citations

Background: 3,4-methylenedioxymethamphetamine (MDMA) produces “prosocial” effects that contribute to its recreational use. Few studies have examined the cognitive and behavioral mechanisms by which MDMA produces these effects. Here we examined the effect of MDMA on a specific prosocial effect, i.e. generosity, using a task in which participants make decisions about whether they or another...

DOI: 10.1177/0269881115573806 (opens in new tab) MDMA Generosity Prosocial behavior Developmental psychology +2

Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Metabolic Brain Disease February 2015 Sara Soleimani Asl, Bita Saifi, Abolhasan Sakhaie et al.

Exposure to 3, 4-methylenedioxymethamphetamine (MDMA) can lead to spatial memory impairments and hippocampal cell death. Numerous evidence indicates that the antioxidant N-acetylcysteine (NAC) exerts protective effects in the brain. The present study evaluates the effects of NAC on MDMA-induced neurotoxicity. We intraperitoneally injected 28 adult male Sprague-Dawley rats (200-250 g) with...

Legal highs: staying on top of the flood of novel psychoactive substances

Therapeutic Advances in Psychopharmacology January 26, 2015 David Baumeister, Luis M. Tojo, Derek K. Tracy 158 citations

There has been growing clinical, public, and media awareness and concern about the availability and potential harmfulness of so-called ‘legal highs’, which are more appropriately called new or novel psychoactive substances (NPS). A cat-and-mouse process has emerged wherein unknown chemists and laboratories are producing new, and as yet nonproscribed, compounds for human consumption; and as soon...

Intravenous self-administration of mephedrone, methylone and MDMA in female rats

Neuropharmacology January 17, 2015 Kevin M Creehan, Sophia A. Vandewater, Michael A. Taffe 98 citations

Male rats will intravenously self-administer (IVSA) the substituted cathinone stimulants (“bath salts”) mephedrone (4-methylmethcathione) and methylone (3,4-methylenedioxymethcathinone) robustly, whereas the IVSA of 3,4-methylenedioxymethamphetamine (MDMA) is inconsistent in many rat models. There are no data available on the self-administration of these drugs in female rats, thus a study was...

Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice.

PLoS One 2015 Emily M Johansson, María S García-Gutiérrez, Maria Moscoso‐castro et al.

The recreational drugs, alcohol and 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") have both been shown to cause immune activation in vivo, and they are linked to cognitive impairment and anxiety-like behaviors in rodents. The neuronal effects of these drugs in the hippocampal area, an area that has been a focus of studies aiming to explain the mechanisms underlying anxiety...

The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.

Journal of Psychoactive Drugs 2015 Timothy Amoroso

Prior to 1985, ±3,4-methylenedioxymethamphetamine (MDMA) was readily used as a psychotherapeutic adjunct. As MDMA became popular in treating various psychiatric illnesses by mental health professionals, the public started to abuse the MDMA-containing recreational drug "ecstasy." This alarmed the DEA, which led to emergency scheduling of MDMA as a Schedule I drug. Due to its scheduling in 1985,...

DOI: 10.1080/02791072.2015.1094156 (opens in new tab) Full text (opens in new tab) PTSD MDMA-Assisted Psychotherapy Posttraumatic stress disorder

Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.

Psychological Medicine January 2015 C A Roberts, M A Wetherell, John E. Fisk et al.

Cognitive deficits are well documented in ecstasy (3,4-methylenedioxymethamphetamine; MDMA) users, with such deficits being taken as evidence of dysregulation of the serotonin (5-hydroxytryptamine; 5-HT) system. More recently neuroimaging has been used to corroborate these deficits. The present study aimed to assess multitasking performance in ecstasy polydrug users, polydrug users and...

"Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug Misuse.

International review of neurobiology 2015 Jenny Bearn, Matthew O'Brien

Eating, drinking, sexual activity, and parenting invoke pleasure, an emotion that promotes repetition of these behaviors, are essential for survival. Euphoria, a feeling or state of intense excitement and happiness, is an amplification of pleasure, aspired to one's essential biological needs that are satisfied. People use party drugs as a shortcut to euphoria. Ecstasy...

Application of the Passionate Attachment Model to Recreational Use of MDMA/Ecstasy

Journal of Psychoactive Drugs 2015 Alan K. Davis, Harold Rosenberg 15 citations

Those who are not addicted to ecstasy, but who use it persistently over time, could be viewed as having a "passionate attachment" to a highly valued activity. To evaluate the associations of obsessive and harmonious passion with psychological and behavioral aspects of ecstasy consumption, we recruited a community sample of ecstasy users to complete a modified version of the Passion Scale...